The global veterinary artificial insemination market is anticipated to reach USD 11.25 billion by 2030 and is projected to grow at a CAGR of 6.34% from 2024 to 2030, according to a new report by Grand View Research, Inc. The key factors driving the market growth include increasing consumption of animal protein, growing demand for livestock productivity, and adoption of sexed semen. In March 2023, Genetics Australia - the country’s largest artificial breeding supplier announced that it would merge with URUS - a leading player in the veterinary artificial insemination industry. This would provide Genetics Australia access to global markets in marketing Australian genetics.
The COVID-19 pandemic resulted in many challenges including dampened growth, decreased sales and marketing activities, supply chain hurdles, and delays in the delivery of AI services. The erratic and uncertain consumption patterns in several key markets exacerbated by sporadic lockdowns and logistical bottlenecks further increased the uncertainty in the market. The growth was also dampened by other factors such as the African Swine-Fever. Genus, for instance, reported labor shortages, adverse impact on retail food service demand and meat packing capacity, and international logistics delays due to the pandemic. The company indicated that in the near-term, feed input costs, ASF, and COVID-19 implications would continue to exert pressure on the global porcine industry, particularly in China and Europe. In North America, the pandemic led to packing plant slowdowns during H1 of 2021.
To fulfill the continuously increasing demand for meat and dairy products, market players are expanding artificial insemination solutions to breed high-quality livestock and enhance production. For example, in August 2020, Cogent with AB Europe launched a novel sexed semen service for U.K. sheep producers. In September 2021, LIC- an agritech co-operative based in New Zealand launched a sexed semen lab in the country to meet the growing demand. This boosted the cooperative’s capabilities to artificially inseminate about 4.5 million cattle between the Spring mating season of September to December 2021. Developing regions such as Latin America are also contributing to the market growth for veterinary artificial insemination. For instance, Brazil, one of the major countries in the region has been adopting AI increasingly for the past decade. The country has also deployed Fixed-Time Artificial Insemination (FTAI) techniques to increase profitability and success rate.
Request a free sample copy or view report summary: Veterinary Artificial Insemination Market Report
Based on solutions, the services segment led the market with the largest revenue share of 42.05% in 2023. The semen segment on the other hand is anticipated to grow at the fastest CAGR of 6.98% over the forecast period
Artificial insemination (AI) offers a safe and regulated environment for breeding, lowering the possibility of mishaps or injuries that could happen during natural mating. Furthermore, AI gives breeders more control over the breeding process, ensuring that mating takes place under the best possible circumstances, and raises the likelihood of viable pregnancies
Based on distribution channel, the private segment led the market with the largest revenue share of 64.32% in 2023 and is also projected to grow at the fastest CAGR over the forecast period
Based on animal type, the bovine segment held the market with the largest revenue share of 40.52% in 2023. The swine segment is estimated to grow at the fastest CAGR of 6.81% during the forecast period
North America dominated the market with the revenue share of 30.28% in 2023. Latin America region is estimated to grow at the fastest CAGR of 7.07% over the forecast period
As the global population continues to grow, there is an increasing demand for animal protein, including meat, milk, and eggs. This drives the need for efficient breeding practices to optimize livestock production, which includes the use of artificial insemination to improve genetics and reproductive efficiency
Grand View Research has segmented the global veterinary artificial insemination market report based on solutions, animal type, distribution channel, and region:
Veterinary Artificial Insemination Solutions Outlook (Revenue, USD Million, 2018 - 2030)
Equipment & Consumables
Semen
Normal
Sexed
Services
Veterinary Artificial Insemination Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
Bovine
Swine
Ovine & Caprine
Equine
Other Animals
Veterinary Artificial Insemination Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
Private
Public
Veterinary Artificial Insemination Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Norway
Sweden
Denmark
Asia Pacific
Japan
India
China
South Korea
Thailand
Australia
Latin America
Brazil
Mexico
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
List of Key Players of Veterinary Artificial Insemination Market
Genus
URUS Group LP
CRV
SEMEX
IMV Technologies
Select Sires Inc.
Swine Genetics International
Shipley Swine Genetics
Stallion AI Services Ltd
STgenetics
"The quality of research they have done for us has been excellent..."